These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9915037)

  • 1. Why the Scandinavian countries have not implemented universal vaccination against hepatitis B.
    Iwarson S
    Vaccine; 1998 Nov; 16 Suppl():S56-7. PubMed ID: 9915037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Report from Working Group 3 (the Czech Republic, Denmark, Finland, Norway, The Netherlands, Slovakia, Sweden and the UK).
    Iwarson S
    Vaccine; 1998 Nov; 16 Suppl():S63-4. PubMed ID: 9915040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal hepatitis B immunization: infant, and infant plus adolescent immunization.
    Bonanni P
    Vaccine; 1998 Nov; 16 Suppl():S17-22. PubMed ID: 9915027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of hepatitis B immunization programmes in 1998.
    Kane MA
    Vaccine; 1998 Nov; 16 Suppl():S104-8. PubMed ID: 9915049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global progress toward universal childhood hepatitis B vaccination, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(36):868-70. PubMed ID: 12970620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B infection control in Colombian Amazon after 15 years of hepatitis B vaccination. Effectiveness of birth dose and current prevalence.
    Garcia D; Porras A; Rico Mendoza A; Alvis N; Navas MC; De La Hoz F; De Neira M; Osorio E; Valderrama JF
    Vaccine; 2018 May; 36(19):2721-2726. PubMed ID: 29609968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of early hepatitis B immunization programs for newborns and infants.
    Van Herck K; Van Damme P
    Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
    Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
    Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
    Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
    Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of epidemiology and disease burden of hepatitis B in the European region.
    Roure C
    Vaccine; 1995; 13 Suppl 1():S18-21. PubMed ID: 7571821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of hepatitis B in central and eastern Europe (CEE) and the Newly Independent States (NIS): recommendations of the October 1996 meeting in Siófok, Hungary.
    Meheus A
    Vaccine; 1998 Nov; 16 Suppl():S99-103. PubMed ID: 9915048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of hepatitis B vaccination into national immunisation programmes. Viral Hepatitis Prevention Board.
    Van Damme P; Kane M; Meheus A
    BMJ; 1997 Apr; 314(7086):1033-6. PubMed ID: 9112852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From Cannes 1993 to the present.
    Van Damme P; Verwimp G
    Vaccine; 1998 Nov; 16 Suppl():S3-6. PubMed ID: 9915024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001.
    Van Damme P; Vorsters A
    J Med Virol; 2002 Jul; 67(3):433-9. PubMed ID: 12116040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Success stories in the implementation of universal hepatitis B vaccination: an update on Italy.
    Bonanni P; Crovari P
    Vaccine; 1998 Nov; 16 Suppl():S38-42. PubMed ID: 9915032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.
    Zhao S; Xu Z; Lu Y
    Int J Epidemiol; 2000 Aug; 29(4):744-52. PubMed ID: 10922354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of hepatitis-B vaccination in Ivory Coast: the case of the Grand Bassam health district.
    Magoni M; Ekra KD; Aka LN; Sita KS; Kanga K
    Ann Trop Med Parasitol; 2009 Sep; 103(6):519-27. PubMed ID: 19695157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccination against hepatitis B and epidemiological situation of this disease in European countries in the years 1990-2001].
    Magdzik W
    Przegl Epidemiol; 2006; 60(2):179-84. PubMed ID: 16964667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [National hepatitis B vaccination closer to implementation, but not soon enough; recommendations from the Dutch Health Council].
    Galama JM
    Ned Tijdschr Geneeskd; 2001 Jul; 145(28):1339-42. PubMed ID: 11484429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.